Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
about
Treatment of nonalcoholic fatty liver disease: role of AMPK.Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models.A unified molecular mechanism for the regulation of acetyl-CoA carboxylase by phosphorylation.Crystal structure of FabZ-ACP complex reveals a dynamic seesaw-like catalytic mechanism of dehydratase in fatty acid biosynthesis.Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.Modeling fructose-load-induced hepatic de-novo lipogenesis by model simplification.Analysis of Arabidopsis Accessions Hypersensitive to a Loss of Chloroplast Translation.Lipid Synthesis Is a Metabolic Liability of Non-Small Cell Lung Cancer.Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.Network analyses identify liver-specific targets for treating liver diseases.Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA).Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Acetyl-CoA carboxylase 1 regulates endothelial cell migration by shifting the phospholipid composition.Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.Actionable Metabolic Pathways in Heart Failure and Cancer—Lessons From Cancer Cell Metabolism.AMPK Activation Reduces Hepatic Lipid Content by Increasing Fat Oxidation In Vivo
P2860
Q30248230-26BE4A49-F1B7-4264-82DC-61DF66CC9C66Q37317840-181DD3AA-736E-4403-A02E-EF9375CE40DCQ37447735-B57F540F-055F-4204-BE85-B12D38291FD5Q37482878-58DD21A9-1F13-47FA-AFE9-6D9CE0DDDE16Q37583677-81FCDEF8-77CF-4B8C-AAB3-87AB9D5C0E17Q37727871-AC71AC4E-5C8E-486F-B77D-30C8A8595FDDQ38806212-BB68F36E-8514-404A-9E84-454760ED75F0Q38809395-938025A8-117A-4A8B-A84B-16C7CDE1BFA6Q39071340-D44046B3-D9F7-401D-BBCF-DD9D16295706Q39377977-E6793B84-D9DC-45F6-B333-B9489C6A1F3BQ39432694-9ACD1DC4-1B88-4E15-A835-96A1DDF47B90Q41526807-72F7EC6D-91C0-40AF-9A30-009883386F6AQ41837751-2715B831-FD79-48E3-9D0B-43D52F65966CQ42127633-C213B1EF-8022-4F64-8B98-A43323FA8CBCQ42367659-DBD62ADF-5C68-4345-8B63-C7135C461CE9Q42379258-1AA95638-B81C-4022-A165-FC83A7AB3FD8Q42695159-84B0BC23-EE1C-423B-AFD1-958815137C01Q47779219-43F7D7AE-7921-42DE-BCC2-063E2A200A9FQ50058773-8D54C6BC-4701-401B-A5A4-3C532696421CQ53730590-D83722C6-6FAE-4A4E-8212-1E3DCF5A64B4Q54980729-2E4E9469-B44D-4928-AEA0-4BB508276AC6Q55401962-592CDA0A-CEC7-48CD-B006-545E7D328026Q58716064-EF11A2A4-7905-43C1-8202-F79EEF0576F5
P2860
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@ast
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@en
type
label
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@ast
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@en
prefLabel
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@ast
Acetyl-CoA carboxylase inhibit ...... odulates dyslipidemia in rats.
@en
P2093
P2860
P921
P356
P1476
Acetyl-CoA carboxylase inhibit ...... modulates dyslipidemia in rats
@en
P2093
Asish K Saha
Debamita Paul
Geraldine Harriman
H James Harwood
Jeremy Greenwood
Rosana Kapeller
Ruiying Wang
Sathesh Bhat
William F Westlin
Xinyi Huang
P2860
P304
P356
10.1073/PNAS.1520686113
P407
P50
P577
2016-03-14T00:00:00Z